Puma Biotechnology (PBYI) Other Working Capital Changes (2018 - 2026)
Puma Biotechnology (PBYI) posted Other Working Capital Changes of -$60000.0 for Q1 2026, down 330.77% on a QoQ basis from $26000.0 in Q4 2025, and down 957.14% year-over-year from $7000.0 in Q1 2025.
Puma Biotechnology (PBYI) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Puma Biotechnology's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$60000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 957.14% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98000.0 (up 162.42% YoY) and the FY2025 annual result came in at $165000.0, up 120.1% from the prior year.
- Other Working Capital Changes was -$60000.0 for Q1 2026 at Puma Biotechnology, down from $26000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.7 million in Q2 2022 and bottomed at -$2.0 million in Q1 2023.
- A 5-year average of -$14764.7 and a median of -$14000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 3385.71% in 2022, while the deepest fall reached 41925.0% in 2022.
- Puma Biotechnology's Other Working Capital Changes stood at -$1.7 million in 2022, then surged by 35.99% to -$1.1 million in 2023, then soared by 86.52% to -$145000.0 in 2024, then jumped by 117.93% to $26000.0 in 2025, then sank by 330.77% to -$60000.0 in 2026.
- Business Quant data shows PBYI's Other Working Capital Changes at -$60000.0 in Q1 2026, $26000.0 in Q4 2025, and $157000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |